What is he best known for?
The fields of study he is best known for:
- Cancer
- Immune system
- Gene
His primary areas of study are Immunology, Immunotherapy, Immune system, Cancer research and Cancer immunotherapy.
His Immunology research includes elements of Cytotoxic T cell, Internal medicine and Cell culture.
His Immunotherapy study combines topics from a wide range of disciplines, such as T cell, Immunity and Vaccination.
His Immune system research incorporates elements of Lymphocyte, Receptor, Antibody and Antigen.
His Cancer research research is multidisciplinary, relying on both CD86 and Interleukin 8.
Cancer covers Ignacio Melero research in Cancer immunotherapy.
His most cited work include:
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial (1507 citations)
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C. (515 citations)
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C. (515 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Immunology, Immunotherapy, Cancer research, Immune system and Internal medicine.
Ignacio Melero has researched Immunology in several fields, including Interleukin 12 and Genetic enhancement.
He studies Cancer immunotherapy, a branch of Immunotherapy.
His Cancer research research includes themes of Immunogenic cell death, Cytotoxic T cell, Cell culture and CD8.
The Immune system study combines topics in areas such as Antibody and CD40.
His work on Nivolumab, Hepatocellular carcinoma and Sorafenib as part of general Internal medicine study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
He most often published in these fields:
- Immunology (47.07%)
- Immunotherapy (39.19%)
- Cancer research (36.90%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (36.90%)
- Immunotherapy (39.19%)
- Immune system (29.01%)
In recent papers he was focusing on the following fields of study:
Ignacio Melero focuses on Cancer research, Immunotherapy, Immune system, Internal medicine and Cancer immunotherapy.
His Cancer research study combines topics in areas such as Cytotoxic T cell, CD8, Antigen and Monoclonal antibody.
Immunotherapy is a primary field of his research addressed under Immunology.
In the subject of general Immune system, his work in Immunity is often linked to Attenuated vaccine, thereby combining diverse domains of study.
His Internal medicine research focuses on Oncology and how it relates to Atezolizumab, Chemotherapy, Inflammation and Phases of clinical research.
His work deals with themes such as T cell, Adoptive cell transfer, Chimeric antigen receptor, Receptor and Interleukin 12, which intersect with Cancer immunotherapy.
Between 2018 and 2021, his most popular works were:
- Dendritic cells in cancer immunology and immunotherapy. (256 citations)
- Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma. (179 citations)
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3 (179 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Immune system
- Gene
Ignacio Melero mostly deals with Cancer research, Immune system, Immunotherapy, Cancer immunotherapy and Cancer.
His Cancer research study incorporates themes from Immune checkpoint, CD137, Cytotoxic T cell, Monoclonal antibody and Immunogenic cell death.
Ignacio Melero does research in Immune system, focusing on Tumor microenvironment specifically.
His Immunotherapy research incorporates themes from Colitis, Radioimmunotherapy, Melanoma, Lung cancer and Radiation therapy.
His Cancer immunotherapy research is multidisciplinary, relying on both T cell, CTLA-4, Chimeric antigen receptor, Adoptive cell transfer and Antigen.
The subject of his Antigen research is within the realm of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
